BNGO News and Press, Bionano Genomics Inc. From 06/04/21

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Today, investors in  Bionano Genomics  (NASDAQ: BNGO ) and BNGO stock had a very nice green day. Shares of BNGO stock closed the day 9% higher as volatility continued to pick up among various speculative ...

BNGO is embarking on an ambitious plan to change the lab and diagnostics standards, putting the proceeds of the new equity offering into good use. Although the company achieved high growth in Q1, it stems from a low base, making it hard to justify current price levels, even if the rev...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips After Bionano (NASDAQ: BNGO ) reported very strong first-quarter results and showed that its Saphyr DNA analysis tool is progressing on multiple fronts, I remain extremely bullish on BNGO stock. Source: Connect wor...

If you're looking for life science stocks that could make you a millionaire, Bionano Genomics (NASDAQ: BNGO) is beginning to look like a strong candidate. The company's quickly cornering the market for a service that can find gene mutations that DNA sequencing machines tend to miss....

Bionano stock has skyrocketed in 2021 after narrowly avoiding being delisted in 2020 due to its shares trading <$1. The company is commercializing Saphyr, a novel approach to performing cytogenetics and discovery research using Optical Genome Mapping as opposed to short- or long-fo...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips It’s been quite the year for the life sciences company, Bionano Genomics (NASDAQ: BNGO ). BNGO stock was trading for as little as 50 cents late last year before the short squeeze lifted the stock past it past t...

Bionano Genomics, Inc. (BNGO) Oppenheimer MedTech, Tools & Diagnostics Summit Conference Call May 26, 2021 08:00 AM ET Company Participants Robert Holmlin - President and Chief Executive Officer Conference Call Participants Presentation Robert Holmlin Well, I am really excited to be here ...

The biotech industry has witnessed solid growth over the past year, in large measure attributable to the demand for drugs to fight COVID-19, among other diseases. The integration of technology and successful clinical trials of drugs for treating critical ailments have boosted Wall Street ...

SAN DIEGO, May 19, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that company management will present virtually at the Oppenheimer MedTech, Tools & Diagnostics Summit being held on May 26, 2021. The presentation will be available to view on the Eve...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips The recent highlights section of Bionano Genomics’ (NASDAQ: BNGO ) 2021 first-quarter report said it all about BNGO stock. In the quarter ended March 31, the company shipped 11 Saphyr systems, more than do...